Tor K Larsen
Overview
Explore the profile of Tor K Larsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
797
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ottesen A, T V Hegelstad W, Joa I, Opjordsmoen S, Rund B, Rossberg J, et al.
Psychol Med
. 2023 May;
53(6):2399-2408.
PMID: 37144963
Background: To what extent psychotic symptoms in first-episode psychosis (FEP) with a history of childhood interpersonal trauma (CIT) are less responsive to antipsychotic medication is not known. In this longitudinal...
2.
Hoprekstad G, Kjelby E, Gjestad R, Fathian F, Larsen T, Reitan S, et al.
Schizophr Res
. 2023 Jan;
252:77-87.
PMID: 36634451
Depression occurs frequently in all phases of schizophrenia spectrum disorders. Altered activity in the immune system is seen in both depression and schizophrenia. We aimed to uncover depressive trajectories in...
3.
Fathian F, Gjestad R, Kroken R, Loberg E, Reitan S, Fleichhacker W, et al.
Schizophr Res
. 2022 Feb;
241:174-183.
PMID: 35131596
Background: A potential role of inflammatory pathways in the pathology of schizophrenia has been suggested for at least a subgroup of patients. Elevated levels of the inflammatory marker C-reactive protein...
4.
Hoekstra S, Bartz-Johannessen C, Sinkeviciute I, Reitan S, Kroken R, Loberg E, et al.
NPJ Schizophr
. 2021 Aug;
7(1):39.
PMID: 34408155
Current guidelines for patients with schizophrenia spectrum disease do not take sex differences into account, which may result in inappropriate sex-specific treatment. In the BeSt InTro study, a total of...
5.
Melle I, Olav Johannesen J, Haahr U, Hegelstad W, Joa I, Langeveld J, et al.
World Psychiatry
. 2017 May;
16(2):217-218.
PMID: 28498600
No abstract available.
6.
Bjornestad J, Joa I, Larsen T, Langeveld J, Davidson L, Hegelstad W, et al.
Front Psychol
. 2016 Oct;
7:1491.
PMID: 27757090
Predictors of long-term symptomatic remission are crucial to the successful tailoring of treatment in first episode psychosis. There is lack of studies distinguishing the predictive effects of different social factors....
7.
Bay N, Bjornestad J, Johannessen J, Larsen T, Joa I
Early Interv Psychiatry
. 2014 May;
10(1):71-6.
PMID: 24861169
Aim: This qualitative study is a sub-study of the early 'Treatment and Intervention in Psychosis Study' (TIPS-2), a program for early intervention strategies for people experiencing a first episode of...
8.
Stain H, Bronnick K, Hegelstad W, Joa I, Johannessen J, Langeveld J, et al.
Schizophr Bull
. 2013 Nov;
40(6):1491-8.
PMID: 24282322
Background: Social functioning is an important treatment outcome for psychosis, and yet, we know little about its relationship to trauma despite high rates of trauma in people with psychosis. Childhood...
9.
Barder H, Sundet K, Rund B, Evensen J, Haahr U, Hegelstad W, et al.
Front Hum Neurosci
. 2013 Oct;
7:643.
PMID: 24109449
Objective: Neurocognitive impairment is commonly reported at onset of psychotic disorders. However, the long-term neurocognitive course remains largely uninvestigated in first episode psychosis (FEP) and the relationship to clinically significant...
10.
Hegelstad W, Joa I, Barder H, Evensen J, Haahr U, Johannessen J, et al.
Early Interv Psychiatry
. 2013 Jun;
8(4):323-31.
PMID: 23773272
Aim: The Scandinavian TIPS project engineered an early detection of psychosis programme that sought to reduce the duration of untreated psychosis (DUP) through early detection teams and extensive information campaigns...